- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to investigate the safety and efficacy of the UK-390,957 individual flexible dose group (including doses up to 10 mg) compared to placebo. Efficacy will be assessed using IELT at Week 8 and adverse events will be summarized by treatment arm.
Critère d'inclusion
- premature ejaculation